Flu News and Research

RSS

Study finds October-born kids less likely to catch flu post-vaccination

Study shows October as the optimal month for influenza vaccination in young children, aligning with CDC guidelines to maximize protection against seasonal flu.

26 Feb 2024

Study reveals BCG vaccine's unexpected role in fighting influenza

As Canada's flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses.

26 Feb 2024

Researchers develop promising recombinant flu vaccine using nanoliposome technology

Recombinant protein vaccines, like the Novavax vaccine used to fight COVID-19, offer several advantages over conventional vaccines.

24 Feb 2024

Researchers identify potential treatment for cardiovascular disease linked to Type 2 diabetes

New research at the Roy Blunt NextGen Precision Health building has discovered a potential treatment for an underlying cause of cardiovascular disease in people with Type 2 diabetes.

23 Feb 2024

October found to be the optimum time to vaccinate against influenza

The optimum time to vaccinate young infants against influenza.

22 Feb 2024

October births linked to higher flu vaccination and lower diagnosis rates

Children born in October are both more likely to be vaccinated against influenza and least likely to be diagnosed with influenza compared with children born in other months, finds a US study published by The BMJ today.

21 Feb 2024

CDC studies show effectiveness of flu vaccines across all age groups

The prospect of the worrisome triple threat of COVID, RSV and flu was assuaged last year by the effectiveness of flu vaccines.

19 Feb 2024

TB cases in England spike by 10.7% in 2023

Figures published today by the UK Health Security Agency (UKHSA) in its TB annual report, show that tuberculosis cases in England in 2022 were stable compared to 2021 (4,380 in 2022 compared to 4,411 in 2021).

15 Feb 2024

Fluid-filled lung sac found to be the hub for virus-eating cells

Scientists have long thought of the fluid-filled sac around our lungs merely as a cushion from external damage. Turns out, it also houses potent virus-eating cells that rush into the lungs during flu infections.

14 Feb 2024

New study finds 4’-fluorouridine effective against avian influenza in vitro and in vivo

A PLOS Pathogens study reveals 4’-fluorouridine effectively combats avian influenza in vitro and in animal models, showing promise as a treatment that overcomes resistance and reduces disease severity without significant adverse effects.

11 Feb 2024

CARB-X awards $1.8 million to Visby Medical to develop a portable rapid PCR test for gonorrhea

Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award up to US$1.8 million to biotechnology company, Visby Medical, to develop a portable rapid polymerase chain reaction (PCR) diagnostic to detect the presence of the pathogen that causes gonorrhea, Neisseria gonorrhoeae (NG), and its susceptibility to ciprofloxacin, a former frontline oral antibiotic that can no longer treat resistant NG.

9 Feb 2024

Do we simply not care about old people?

The covid-19 pandemic would be a wake-up call for America, advocates for the elderly predicted: incontrovertible proof that the nation wasn't doing enough to care for vulnerable older adults.

9 Feb 2024

Promising influenza drug candidate shows activity against resistant variants

Influenza A viruses with induced resistance to a new candidate antiviral drug were found to be impaired in cell culture and weakened in animals, according to a study by researchers in the Center for Translational Antiviral Research at Georgia State University.

6 Feb 2024